Clinical Trials Browser

Breast Carcinoma In Situ × Naltrexone × Clear all

NCT02137252 2021-11-16

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

Phase 2 Terminated

3 enrolled 4 charts

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Lobular